These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16751021)

  • 1. Eosinophil beta 1 integrin activation state correlates with asthma activity in a blind study of inhaled corticosteroid withdrawal.
    Johansson MW; Barthel SR; Swenson CA; Evans MD; Jarjour NN; Mosher DF; Busse WW
    J Allergy Clin Immunol; 2006 Jun; 117(6):1502-4. PubMed ID: 16751021
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhaled corticosteroid dose reduction in childhood asthma: is nitrosopnea informative?
    Gaston B
    Am J Respir Crit Care Med; 2005 May; 171(10):1065-6. PubMed ID: 15879424
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaled corticosteroid therapy in asthma: a potential problem with high doses.
    Clarke BL
    Ann Allergy Asthma Immunol; 2006 Mar; 96(3):387-9. PubMed ID: 16597071
    [No Abstract]   [Full Text] [Related]  

  • 4. Asthma exacerbations and inhaled corticosteroids.
    Fardon T; Gray R; Lipworth B
    Lancet; 2004 Apr; 363(9416):1235; author reply 1235-6. PubMed ID: 15081662
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
    Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
    Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAL eotaxin and IL-5 in asthma, and the effects of inhaled corticosteroid and beta2 agonist.
    Feltis BN; Reid DW; Ward C; Walters EH
    Respirology; 2004 Nov; 9(4):507-13. PubMed ID: 15612963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma.
    Vignola AM; Chiappara G; Siena L; Bruno A; Gagliardo R; Merendino AM; Polla BS; Arrigo AP; Bonsignore G; Bousquet J; Chanez P
    J Allergy Clin Immunol; 2001 Nov; 108(5):738-46. PubMed ID: 11692098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.
    in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH
    Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
    Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
    J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of inhaled corticosteroids in the treatment of asthma.
    Barnes N
    Respir Med; 1994 Aug; 88 Suppl A():1-3; discussion 3-4. PubMed ID: 7972987
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciclesonide (Alvesco)-a new inhaled corticosteroid for asthma.
    Med Lett Drugs Ther; 2008 Sep; 50(1295):75-6. PubMed ID: 18800024
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma.
    Li AM; Tsang TW; Lam HS; Sung RY; Chang AB
    Respirology; 2008 May; 13(3):400-7. PubMed ID: 18399863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non-asthmatic volunteers.
    Menzies-Gow AN; Flood-Page PT; Robinson DS; Kay AB
    Clin Exp Allergy; 2007 Jul; 37(7):1023-32. PubMed ID: 17581195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor kappaB in asthma.
    Hart L; Lim S; Adcock I; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 2000 Jan; 161(1):224-31. PubMed ID: 10619824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.
    Trigg CJ; Manolitsas ND; Wang J; Calderón MA; McAulay A; Jordan SE; Herdman MJ; Jhalli N; Duddle JM; Hamilton SA
    Am J Respir Crit Care Med; 1994 Jul; 150(1):17-22. PubMed ID: 8025745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhaled corticosteroid on an immunoreactive thymus and activation-regulated chemokine expression in the bronchial biopsies from asthmatics.
    Hoshino M; Nakagawa T; Sano Y; Hirai K
    Allergy; 2005 Mar; 60(3):317-22. PubMed ID: 15679716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
    Koopmans JG; Lutter R; Jansen HM; van der Zee JS
    J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
    Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
    Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil apoptosis and the resolution of airway inflammation in asthma.
    Woolley KL; Gibson PG; Carty K; Wilson AJ; Twaddell SH; Woolley MJ
    Am J Respir Crit Care Med; 1996 Jul; 154(1):237-43. PubMed ID: 8680686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safer inhaled corticosteroid therapy for asthma.
    Chapman KR
    Pediatrics; 2008 Jan; 121(1):179-80. PubMed ID: 18166572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.